Want to see JBIO full AI Analyst Report?
Total Valuation
Jade Biosciences has a market cap or net worth of $1.31B. The enterprise value is $495.99M.
Market Cap$1.31B
Enterprise Value$495.99M
Share Statistics
Jade Biosciences has 60,859,875 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding60,859,875
Owned by Insiders8.37%
Owned by Institutions47.09%
Financial Efficiency
Jade Biosciences’s return on equity (ROE) is -0.38 and return on invested capital (ROIC) is -34.07%.
Return on Equity (ROE)-0.38
Return on Assets (ROA)-0.36
Return on Invested Capital (ROIC)-34.07%
Return on Capital Employed (ROCE)-0.34
Revenue Per Employee0.00
Profits Per Employee-2.55M
Employee Count50
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Jade Biosciences is ―. Jade Biosciences’s PEG ratio is 0.04.
PE Ratio―
PS Ratio0.00
PB Ratio1.46
Price to Fair Value1.46
Price to FCF-5.10
Price to Operating Cash Flow-10.68
PEG Ratio0.04
Income Statement
In the last 12 months, Jade Biosciences had revenue of 0.00 and earned -127.41M in profits. Earnings per share was -4.06.
Revenue0.00
Gross Profit0.00
Operating Income-113.54M
Pretax Income-127.35M
Net Income-127.41M
EBITDA-127.33M
Earnings Per Share (EPS)-4.06
Cash Flow
In the last 12 months, operating cash flow was -116.39M and capital expenditures -196.00K, giving a free cash flow of -116.58M billion.
Operating Cash Flow-116.39M
Free Cash Flow-116.58M
Free Cash Flow per Share-1.92
Dividends & Yields
Jade Biosciences pays an annual dividend of $2.4, resulting in a dividend yield of 14.68%
Dividend Per Share$2.4
Dividend Yield14.68%
Payout Ratio-17.61%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.20
52-Week Price Change93.09%
50-Day Moving Average21.42
200-Day Moving Average15.29
Relative Strength Index (RSI)58.41
Average Volume (3m)1.10M
Important Dates
Jade Biosciences upcoming earnings date is Aug 17, 2026, Before Open (Confirmed).
Last Earnings DateMay 8, 2026
Next Earnings DateAug 17, 2026
Ex-Dividend Date―
Financial Position
Jade Biosciences as a current ratio of 20.33, with Debt / Equity ratio of 0.23%
Current Ratio20.33
Quick Ratio20.33
Debt to Market Cap0.00
Net Debt to EBITDA0.69
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Jade Biosciences has paid 58.00K in taxes.
Income Tax58.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Jade Biosciences EV to EBITDA ratio is -3.11, with an EV/FCF ratio of -4.18.
EV to Sales0.00
EV to EBITDA-3.11
EV to Free Cash Flow-4.18
EV to Operating Cash Flow-4.18
Balance Sheet
Jade Biosciences has $311.30M in cash and marketable securities with $679.00K in debt, giving a net cash position of $310.62M billion.
Cash & Marketable Securities$311.30M
Total Debt$679.00K
Net Cash$310.62M
Net Cash Per Share$5.10
Tangible Book Value Per Share$10.60
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Jade Biosciences is $48.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$48.50
Price Target Upside112.25% Upside
Analyst ConsensusStrong Buy
Analyst Count10
Revenue Growth Forecast―
EPS Growth Forecast94.97%